Top dvm360 articles of 2022: #7

Mike Barletta, DVM, MS, PhD, DACVAA; Tasha McNerney, CVT, CVPP, VTS (Anesthesia & Analgesia); and Kristen Ward, BSN-RN, RVT, VTS, shared their approach at Fetch Nashville 2025

David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to explain treatment for osteoarthritis and the need for individualized patient plans.

The latest canine otitis externa medication is the only FDA-approved, 1-dose, in-clinic treatment for Pseudomonas aeruginosa and other pathogens.

David L. Dycus, DVM, MS, CCRP, DACVS joins Adam Christman, DVM, MBA, to discuss a proactive approach to the diagnosis of osteoarthritis and the best tools for general practice.

Visible particulate matter was observed in 2 products containing dexmedetomidine hydrochloride injection 0.5 mg/mL for dogs and cats.

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of animal testing